Physician profile
Luis Constantin
NPI 1740284082
$9,503.93
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $147 · 2021: $485 · 2022: $6,131 · 2023: $2,701 · 2024: $39.86.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,453 · Travel and Lodging: $1,288.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,453.31 |
| Travel and Lodging | $1,287.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $4,219.00 | 2021-2023 | |
| Medtronic, INC. | $4,002.13 | 2022-2023 | Selectsecure |
| Biosense Webster, INC. | $458.64 | 2021-2023 | Carto 3 |
| Cvrx, INC. | $366.02 | 2022-2024 | Barostim Neo System |
| Abiomed | $258.01 | 2019-2023 | Impella |
| Ge Healthcare | $96.01 | 2023 | |
| Pfizer INC. | $30.58 | 2024 | |
| Axonics, INC. | $24.53 | 2022 | |
| Astrazeneca Pharmaceuticals Lp | $17.50 | 2022 | |
| Amgen INC. | $17.41 | 2023 | Repatha |
| E.R. Squibb & Sons, L.L.C. | $14.10 | 2023 | Camzyos |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luis Constantin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.